Skip to content

Triple-masked randomized comparison of 5mL or 20mL levobupivacaine to femoral triangle block for total knee arthroplasty

Triple-masked randomized comparison of 5mL or 20mL levobupivacaine to femoral triangle block for total knee arthroplasty - Triple-masked randomized comparison of 5mL or 20mL levobupivacaine to femoral triangle block for total knee arthroplasty

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000031890
Enrollment
120
Registered
2018-03-25
Start date
2018-03-21
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee osteoarthritis or knee rheumatoid arthritis

Interventions

Group LV(Low volume): preoperative femoral triangle block with 0.5% levobupivacaine 5mL Group HV(High volume): preoperative femoral triangle block with 0.125% levobupivacaine 20mL

Sponsors

Daiyukai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients scheduled unilateral total knee arthroplasty at Daiyukai General Hospital 2.Adults (>=20 years) with American Society of Anaesthesiologists Physical Status Classification I-III 3.Participants were scheduled for primary unilateral TKA for osteoarthritis 4.Written informed consent is provided

Exclusion criteria

Exclusion criteria: 1.Inability to communicate lucidly 2.Bilateral TKA 3.revision knee arthroplasty 4.Under 20 years old 5.Allergy to any of the drugs used in this study 6.ASA-PS > III 7.Chronic opioid use 8.Diabetes mellitus with sensory disorders 9.Neurological disability 10.Infections around femoral crease 11.Platelet < 5.0 * 10^4 /mcl 12.Pregnancy, possibility of pregnancy, or breast-feeding women 13.Contraindications to peripheral nerve blocks

Design outcomes

Primary

MeasureTime frame
Attainment time of early discharge criteria

Secondary

MeasureTime frame
Postoperative pain score (VRS)(Postoperative 1 hour, time point per 8 hours till postoperative 72 hours) Postoperative motor function (24, 48, 72 hours) Postoperative rehabilitation score and muscle power(24, 48, 72 hours) Consumption of postoperative additional analgesics(72 hours) Complication(72 hours)

Countries

Japan

Contacts

Public ContactNorihiro Sakai

Daiyukai General Hospital Dep. Anaesthesiplogy

sakayline@anes.med.osaka-u.ac.jp+81-586-72-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026